Insulin efficacy in diabetes management

Comparison of efficacy of short-acting insulin (Regular) manufactured by Ronak Daru (Ronulin ®) with manufactured by Exir (Lansulin®) in reducing blood sugar after meals in patients with type 2 diabete

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013040812938N1

Enrollment

Registered

2013-04-24

Start date

2012-12-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabete. Diabetes mellitus

Interventions

Intervention 1: control: manufactured by Exir (Lansulin®). Intervention 2: Ronak Daru (Ronulin ®).

Treatment - Drugs

control: manufactured by Exir (Lansulin®)

Ronak Daru (Ronulin ®)

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: 1-diabetic patients type 2 treated with insulin with or without oral drug. 2-100mg/dl 18 years old*. 5-BMI=30 kg/m2. *We have enrolled patients with age more than 18 years, according to reference 17, 18, 19, and 20.Age don’t be considered as a confounding factor because study has randomized design. exclusion criteria: 1- microvascular and macrovascular complications. 2-hypoglycemia(BS250mg/dl). 3-pregnancy or Breastfeeding. 4- use of glucocorticoides or any drug that lead hyperglycemia. 5- uncontrolled HTN (BP>180/105). 6-iinsulin allergy. 7-use of more than 1.4 U/kg/d insulin. 8-????? Cr>2 mg/dl or LFT>twofold normal range. 9-Patient withdrew from the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Mean of HbA1c in the end of study. Timepoint: HbA1c levels before and after of any intervation. Method of measurement: at before and after of intervation by laboratory with HPLC assay.	—

Secondary

Measure	Time frame
Hypoglycemia. Timepoint: during study. Method of measurement: Bionime Glucometer.;Weight changes. Timepoint: before and after of intervation. Method of measurement: scale.;Hyperglycemia. Timepoint: during study. Method of measurement: Bionime glucometer.;Insulin dosage. Timepoint: during study. Method of measurement: unit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr yunes Panahi

Chemical Injury Research Center

yunespanahi@yahoo.com+98 21 8821 1524

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026